Original Article

A Dose-Response Analysis of Crystalloid Administration during Esophageal Resection

Authors: Morgan Smith, MBBS, Bobby Nossaman, MD


Objectives: The purpose of this retrospective study was to investigate the role of intraoperative crystalloid administration on postoperative hospital length of stay (phLOS) and on the incidence of previously reported adverse events in 100 consecutive patients who underwent esophageal resection.

Methods: The role of previously reported patient demographics, clinical characteristics, and intraoperative crystalloid administration on the duration of phLOS underwent statistical screening criteria for multivariable analysis, including the use of an instrumental variable to measure the role of unmeasured confounders on phLOS. Tests to assess the likelihood of causality also were performed.

Results: When the volumes of intraoperative crystalloids were expressed as dose-response relationships to outcomes, progressive decreases in phLOS, variances in phLOS, and the incidences of unplanned surgical intensive care unit admission, postoperative pneumonia, respiratory failure requiring orotracheal intubation, nonsinus cardiac dysrhythmias, and anastomotic leak were observed. Intraoperative transfusion of packed red blood cells greatly increased the duration of phLOS, which was not associated with estimated blood loss, length of surgical operation, or unplanned surgical intensive care unit admission. Instrumental variable analysis revealed no significant influence on phLOS. Causality tests supported the role of intraoperative crystalloid administration in reducing the duration and variance of phLOS.

Conclusions: A dose-response relationship was clinically observed between intraoperative crystalloid administration and the duration and variance of phLOS and with commonly reported postoperative adverse events. Intraoperative transfusion of packed red blood cells greatly increased phLOS that was not associated with the severity of the surgical operation. Instrumental variables and tests for causality further supported the role of intraoperative crystalloid administration in reducing the duration and variance of phLOS.

Posted in: Gastroenterology53

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.


1. Debakey ME, Ochsner A. Subtotal esophagectomy and esophagogastrostomy for high intrathoracic esophageal lesions. Surgery 1948;23:935-951.
2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65:5-29.
3. Hashimi S, Smith M. Medical evaluation of patients preparing for an esophagectomy. Surg Clin North Am 2012;92:1127-1133.
4. Mortensen MB. Avoiding complications in esophageal cancer surgery. Minerva Chir 2013;68:341-352.
5. Derogar M, Orsini N, Sadr-Azodi O, et al. Influence of major postoperative complications on health-related quality of life among long-term survivors of esophageal cancer surgery. J Clin Oncol 2012;30:1615-1619.
6. Grotenhuis BA, Wijnhoven BP, Grü F, et al. Preoperative risk assessment and prevention of complications in patients with esophageal cancer. J Surg Oncol 2010;101:270-278.
7. Low DE, Kunz S, Schembre D, et al. Esophagectomy-it' not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer. J Gastrointest Surg 2007;11:1395-1402.
8. Cao S, Zhao G, Cui J, et al. Fast-track rehabilitation program and conventional care after esophagectomy: a retrospective controlled cohort study. Support Care Cancer 2013;21:707-714.
9. Cerfolio RJ, Bryant AS, Bass CS, et al. Fast tracking after Ivor Lewis esophagogastrectomy. Chest 2004;126:1187-1194.
10. Kita T, Mammoto T, Kishi Y. Fluid management and postoperative respiratory disturbances in patients with transthoracic esophagectomy for carcinoma. J Clin Anesth 2002;14:252-256.
11. Wei S, Tian J, Song X, et al. Association of perioperative fluid balance and adverse surgical outcomes in esophageal cancer and esophagogastric junction cancer. Ann Thorac Surg 2008;86:266-272.
12. Casado D, López F, Martí R. Perioperative fluid management and major respiratory complications in patients undergoing esophagectomy. Dis Esophagus 2010;23:523-528.
13. Haase O, Raue W, Neuss H, et al. Influence of postoperative fluid management on pulmonary function after esophagectomy. Acta Chir Belg 2013;113:415-422.
14. Raue W, Haase O, Langelotz C, et al. Influence of pre-operative fluid infusion on volume status during oesophageal resection-a prospective trial. Acta Anaesthesiol Scand 2008;52:1218-1225.
15. Neal JM, Wilcox RT, Allen HW, et al. Near-total esophagectomy: the influence of standardized multimodal management and intraoperative fluid restriction. Reg Anesth Pain Med 2003;28:328-334.
16. Kobayashi M, Koh M, Irinoda T, et al. Stroke volume variation as a predictor of intravascular volume depression and possible hypotension during the early postoperative period after esophagectomy. Ann Surg Oncol 2009;16:1371-1377.
17. Tandon S, Batchelor A, Bullock R, et al. Peri-operative risk factors for acute lung injury after elective oesophagectomy. Br J Anaesth 2001;86:633-638.
18. Buise M, Van Bommel J, Mehra M, et al. Pulmonary morbidity following esophagectomy is decreased after introduction of a multimodal anesthetic regimen. Acta Anaesthesiol Belg 2008;59:257-261.
19. Lee EH, Kim HR, Baek SH, et al. Risk factors of postoperative acute kidney injury in patients undergoing esophageal cancer surgery. J Cardiothorac Vasc Anesth 2014;28:936-942.
20. Lanuti M, de Delva PE, Maher A, et al. Feasibility and outcomes of an early extubation policy after esophagectomy. Ann Thorac Surg 2006;82:2037-2041.
21. Colquhoun D. An investigation of the false discovery rate and the misinterpretation of p-values. R Soc Open Sci 2014;1:140216.
22. Glickman ME, Rao SR, Schultz MR. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J Clin Epidemiol 2014;67:850-857.
23. Zhang H, Holford T, Bracken MB. A tree-based method of analysis for prospective studies. Stat Med 1996;15:37-49.
24. Zhang H, Singer BH. Recursive Partitioning and Applications. 2nd ed. New York:Springer;2010.
25. Hammann F, Drewe J. Decision tree models for data mining in hit discovery. Expert Opin Drug Discov 2012;7:341-352.
26. Strobl C, Malley J, Tutz G. An introduction to recursive partitioning: rationale, application, and characteristics of classification and regression trees, bagging, and random forests. Psychol Methods 2009;14:323-348.
27. Austin PC. A comparison of regression trees, logistic regression, generalized additive models, and multivariate adaptive regression splines for predicting AMI mortality. Stat Med 2007;26:2937-2957.
28. SAS Institute. JMP 9 modeling and multivariate methods. https://www.jmp.com/support/downloads/pdf/jmp1002/Modeling-and-Multivariate-Methods.pdf. Accessed April 23, 2019.
29. James KE, White RF, Kraemer HC. Repeated split sample validation to assess logistic regression and recursive partitioning: an application to the prediction of cognitive impairment. Stat Med 2005;24:3019-3035.
30. Rassen JA, Brookhart MA, Glynn RJ, et al. Instrumental variables I: instrumental
variables exploit natural variation in nonexperimental data to estimate causal relationships. J Clin Epidemiol 2009;62:1226-1232.
31. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol 2000;29:722-729.
32. Martens EP, Pestman WR, de Boer A, et al. Instrumental variables: application and limitations. Epidemiology 2006;17:260-267.
33. Katz MH. Study Design and Statistical Analysis: A Practical Guide for Clinicians. New York:Cambridge University Press;2006.
34. Hulley SB, Cummings SR, Browner WS, et al. Designing Clinical Research. 2nd ed. Baltimore, MD:Lippincott Williams & Wilkins;2005.
35. Nossaman VE, Richardson WS, III Wooldridge JB, Jr et al. Role of intraoperative fluids on hospital length of stay in laparoscopic bariatric surgery: a retrospective study in 224 consecutive patients. Surg Endosc 2015;29:2960-2969.
36. Oh TT, Martel CG, Clark AG, et al. Impact of anesthetic predictors on postpartum hospital length of stay and adverse events following cesarean delivery: a retrospective study in 840 consecutive parturients. Ochsner J 2015;15:228-236.
37. Nossaman VE, Richardson WS, Wooldridge JB, Jr et al. Duration of nil per os is causal in hospital length of stay following laparoscopic bariatric surgery. Surg Endosc 2017;31:1901-1905.
38. American College of Surgeons. User guide for the 2012 ACS NSQIP participant use data file. https://www.facs.org/~/media/files/quality%20programs/nsqip/ug12.ash. Published October 2013. Accessed April 23, 2019.
39. Lang TA, Secic M. How to Report Statistics in Medicine: Annotated Guidelines for Authors, Editors, and Reviewers. 2nd ed. Philadelphia:American College of Physicians;2006.
40. Stoltzfus JC. Logistic regression: a brief primer. Acad Emerg Med 2011;18:1099-1104.